Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 2/3 1

Status

Withdrawn 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Keratosis, Actinic 7Cholangiocarcinoma 3Carcinoma, Basal Cell 2Warts 1Neoplasms 1Gallbladder Neoplasms 1Carcinoma, Squamous Cell 1Bowen's Disease 1Bile Duct Neoplasms 1

Interventions

Gemcitabine 7Cisplatin 5Chemotherapy, Adjuvant 3Capecitabine 3pembrolizumab 2Watchful Waiting 2Dihematoporphyrin Ether 2becatecarin 1Tissue Adhesives 1Tegafur 1S 1 (combination) 1Phototherapy 1Photochemotherapy 1Pancreaticojejunostomy 1Oxaliplatin 1Ondansetron 1Leucovorin 1Laser Therapy 1Fluorouracil 1Fentanyl 1Escitalopram 1Enteral Nutrition 1Drug Therapy 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Bile Duct Neoplasms × Photochemotherapy × Clear all
NCT00253617 2013-04-04

Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By Surgery

National Cancer Institute (NCI)

Phase 3 Withdrawn
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡